Cadila Healthcare Ltd. | CADILAHC | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  |  Income Statement  |  Cash Flow  |  Quarterly

Financial Summary Report of Cadila Healthcare Ltd.



CADILAHC
Cadila Healthcare Ltd.

Rs. 345.95
04-Mar-2022

5 Yr Performance

1 Yr Performance

Valuation

Quarterly

Earnings Yield


Quarterly Revenue, Net Income and Adjusted Share Price



Upgrade to Professional Membership

Peer Comparison


AstraZenca Pharma India Ltd.

Aurobindo Pharma Ltd.

Biocon Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Divis Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Fresenius Kabi Oncology Ltd.

Glaxosmithkline Pharmaceuticals Ltd.